Characterization of Human MAGE-A10 protein
| dc.contributor.author | Gyawali, Anjali | |
| dc.date.accessioned | 2022-06-30T11:37:01Z | |
| dc.date.available | 2022-06-30T11:37:01Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | MAGE-A10, the most antigenic protein member of the MAGE-A family of cancer-testis antigen (CTAs), is expressed in tumors but not in normal tissues except for the testis, fetal ovary, and placenta. Their tumor-restricted expression pattern makes these proteins an at tractive target for cancer immunotherapy. The computational molecular weight of MAGE A10 is ~41kDa. However, in the gel, it runs at ~72kDa. In this research, COP5-EBNA cells were transfected with plasmid DNA encoding for different stretches of the MAGE-A10 pro tein, and the size anomalies and localization of the proteins were determined. Our results suggested that the N-terminal region of the protein is responsible for the size anomalies and nuclear localization of the MAGE-A10 protein. | et |
| dc.identifier.uri | http://hdl.handle.net/10062/82955 | |
| dc.language.iso | eng | et |
| dc.rights | embargoedAccess | et |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | MAGE-A10 | et |
| dc.subject | MAGE-A | et |
| dc.subject | cancer-testis antigen | et |
| dc.subject | testis | et |
| dc.subject | cancer immunotherapy | et |
| dc.subject.other | MAGE-A10 | et |
| dc.subject.other | MAGE-A | et |
| dc.subject.other | vähi-testise antigeen | et |
| dc.subject.other | testis | et |
| dc.subject.other | vähi immuunteraapia | et |
| dc.title | Characterization of Human MAGE-A10 protein | et |
| dc.type | info:eu-repo/semantics/bachelorThesis | et |